相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The unmet need in rheumatology: Reports from the targeted therapies meeting 2017
Kevin L. Winthrop et al.
CLINICAL IMMUNOLOGY (2018)
Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Andrew I. Rutherford et al.
RHEUMATOLOGY (2018)
A Systematic Review and Pooled Analysis of Select Safety Parameters Among Normal Healthy Volunteers Taking Placebo in Phase 1 Clinical Trials
Tina C. Young et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study
Peter Kiessling et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Analysis of a Compartmental Model of Endogenous Immunoglobulin G Metabolism with Application to Multiple Myeloma
Felicity Kendrick et al.
FRONTIERS IN PHYSIOLOGY (2017)
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)? The unmet needs and the clinical grey zone in autoimmune disease management
Roberto Giacomelli et al.
AUTOIMMUNITY REVIEWS (2017)
Approach to asymptomatic creatine kinase elevation
Siamak Moghadam-Kia et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2016)
Risk Factors and Clinical Significance of Lymphopenia in Survivors of the Fontan Procedure for Single-Ventricle Congenital Cardiac Disease
Megan M. Morsheimer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)
Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up
Dustin Anderson et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Rituximab in autoimmune diseases
Katrina L. Randall
AUSTRALIAN PRESCRIBER (2016)
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
Jonathan T. Sockolosky et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity
Jolien Suurmond et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Fully human monoclonal antibocy inibitors of the neonatal Fc receptor reduce circulating IgG in non-human primates
Andrew E. Nixon et al.
FRONTIERS IN IMMUNOLOGY (2015)
Neonatal Fc Receptor Promotes Immune ComplexMediated Glomerular Disease
Florina Olaru et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Clinical chemistry of human FcRn transgenic mice
Carsten Stein et al.
MAMMALIAN GENOME (2012)
Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity
Georg H. Stummvoll et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Creatine-Kinase- and Exercise-Related Muscle Damage Implications for Muscle Performance and Recovery
Marianne F. Baird et al.
JOURNAL OF NUTRITION AND METABOLISM (2012)
The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies
Conglei Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Neonatal Fc Receptor Blockade by Fc Engineering Ameliorates Arthritis in a Murine Model
Dipesh A. Patel et al.
JOURNAL OF IMMUNOLOGY (2011)
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
Hans-Peter Tony et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy
Pingguo Chen et al.
BLOOD (2010)
The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases
Alina Sesarman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Autoantibodies in Autoimmune Diseases
M. Eggert et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Comparing the Autoantibody Levels and Clinical Efficacy of Double Filtration Plasmapheresis, Immunoadsorption, and Intravenous Immunoglobulin for the Treatment of Late-onset Myasthenia Gravis
Jun-Feng Liu et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2010)
Slow responses to standard dose rituximab in immune thrombocytopenic purpura
Kevin Kelly et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Muscular exercise can cause highly pathological liver function tests in healthy men
Jonas Pettersson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Immunoglobulin Replacement Therapy in Children
Maria Garcia-Lloret et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
The four most common pediatric immunodeficiencies
E. Richard Stiehm
JOURNAL OF IMMUNOTOXICOLOGY (2008)
Assessment and clinical interpretation of reduced IgG values
Shradha Agarwal et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2007)
Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade
Liming Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Infants presenting with recurrent infections and low immunoglobulins: Characteristics and analysis of normalization
MA Whelan et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria:: a long term observational study
GH Stummvoll et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Antibody pharmacokinetics and pharmacodynamics
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Intravenous immunoglobulin application following immunoadsorption:: benefit or risk in patients with autoimmune diseases?
S Schmaldienst et al.
RHEUMATOLOGY (2001)
分享论文
